Putting the focus on patients
Facts & Figures

«Day 0»

In future, patients should have access to innovative medicines on the day the product is authorised by Swissmedic («Day 0»).

A strong economic framework
Facts & Figures


Accounting for 46% of all exports, the EU was the Swiss pharmaceutical industry's biggest trading partner in 2019.

Leading in research & development

Pharmacological and technological innovations will bring about a fundamental change in the way medicines are developed and used, enabling new approaches to be adopted in research.

Healthcare system

People in Switzerland benefit from access to high-quality healthcare provision. However, there is still a need for action and improvement in various areas.

show more articles

About us

Interpharma, the association of Switzerland’s research-based pharmaceutical industry, was founded in Basel in 1933.

Interpharma informs the public about issues that are important to the research-based pharmaceutical industry in Switzerland, including the pharma market in Switzerland, healthcare and biomedical research.

Annual report

Information on our key figures and activities in the financial year 2020

read more

Board and Executive Management

Introducing Interpharma

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more


Contact us

read more


Latest information and media contacts for media representatives

read more